126 related articles for article (PubMed ID: 27528501)
1. Disease activity and lifestyle influence comorbidities and cardiovascular events in patients with acromegaly.
Sardella C; Cappellani D; Urbani C; Manetti L; Marconcini G; Tomisti L; Lupi I; Rossi G; Scattina I; Lombardi M; Di Bello V; Marcocci C; Martino E; Bogazzi F
Eur J Endocrinol; 2016 Nov; 175(5):443-53. PubMed ID: 27528501
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of primary somatostatin analogue therapy and pituitary adenomectomy on survival in patients with acromegaly: a retrospective cohort study.
Bogazzi F; Colao A; Rossi G; Lombardi M; Urbani C; Sardella C; Iannelli A; Scattina I; Manetti L; Del Sarto S; Pivonello R; Grasso LF; Lupi I; Auriemma RS; Lombardi G; Martino E
Eur J Endocrinol; 2013 Sep; 169(3):367-76. PubMed ID: 23828855
[TBL] [Abstract][Full Text] [Related]
3. Persistence of Diabetes and Hypertension After Multimodal Treatment of Acromegaly.
González B; Vargas G; de Los Monteros ALE; Mendoza V; Mercado M
J Clin Endocrinol Metab; 2018 Jun; 103(6):2369-2375. PubMed ID: 29618021
[TBL] [Abstract][Full Text] [Related]
4. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
5. Emerging trends in the diagnosis and treatment of acromegaly in Canada.
Vallette S; Ezzat S; Chik C; Ur E; Imran SA; Van Uum S; Rivera J; Caspar-Bell G; Serri O
Clin Endocrinol (Oxf); 2013 Jul; 79(1):79-85. PubMed ID: 23190441
[TBL] [Abstract][Full Text] [Related]
6. The Liege Acromegaly Survey (LAS): a new software tool for the study of acromegaly.
Petrossians P; Tichomirowa MA; Stevenaert A; Martin D; Daly AF; Beckers A
Ann Endocrinol (Paris); 2012 Jun; 73(3):190-201. PubMed ID: 22682917
[TBL] [Abstract][Full Text] [Related]
7. Endothelial progenitor cells are reduced in acromegalic patients and can be restored by treatment with somatostatin analogs.
Fadini GP; Dassie F; Albiero M; Boscaro E; Albano I; Martini C; de Kreutzenberg SV; Agostini C; Avogaro A; Vettor R; Maffei P
J Clin Endocrinol Metab; 2014 Dec; 99(12):E2549-56. PubMed ID: 25144634
[TBL] [Abstract][Full Text] [Related]
8. Comorbidities, treatment patterns and cost-of-illness of acromegaly in Sweden: a register-linkage population-based study.
Lesén E; Granfeldt D; Houchard A; Dinet J; Berthon A; Olsson DS; Björholt I; Johannsson G
Eur J Endocrinol; 2017 Feb; 176(2):203-212. PubMed ID: 27932528
[TBL] [Abstract][Full Text] [Related]
9. Diabetes mellitus induced by somatostatin analogue therapy is not permanent in acromegalic patients.
Cappellani D; Urbani C; Sardella C; Scattina I; Marconcini G; Lupi I; Manetti L; Marcocci C; Bogazzi F
Endocrinol Diabetes Metab; 2019 Jan; 2(1):e00033. PubMed ID: 30815570
[TBL] [Abstract][Full Text] [Related]
10. Effects of medical therapies for acromegaly on glucose metabolism.
Urbani C; Sardella C; Calevro A; Rossi G; Scattina I; Lombardi M; Lupi I; Manetti L; Martino E; Bogazzi F
Eur J Endocrinol; 2013 Jul; 169(1):99-108. PubMed ID: 23660641
[TBL] [Abstract][Full Text] [Related]
11. Hypertension in acromegaly and in the normal population: prevalence and determinants.
Vitale G; Pivonello R; Auriemma RS; Guerra E; Milone F; Savastano S; Lombardi G; Colao A
Clin Endocrinol (Oxf); 2005 Oct; 63(4):470-6. PubMed ID: 16181242
[TBL] [Abstract][Full Text] [Related]
12. Impact of somatostatin analogs versus surgery on glucose metabolism in acromegaly: results of a 5-year observational, open, prospective study.
Colao A; Auriemma RS; Galdiero M; Cappabianca P; Cavallo LM; Esposito F; Grasso LF; Lombardi G; Pivonello R
J Clin Endocrinol Metab; 2009 Feb; 94(2):528-37. PubMed ID: 19001517
[TBL] [Abstract][Full Text] [Related]
13. Determinants of cardiac disease in newly diagnosed patients with acromegaly: results of a 10 year survey study.
Colao A; Pivonello R; Grasso LF; Auriemma RS; Galdiero M; Savastano S; Lombardi G
Eur J Endocrinol; 2011 Nov; 165(5):713-21. PubMed ID: 21868601
[TBL] [Abstract][Full Text] [Related]
14. Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women.
Caron P; Broussaud S; Bertherat J; Borson-Chazot F; Brue T; Cortet-Rudelli C; Chanson P
J Clin Endocrinol Metab; 2010 Oct; 95(10):4680-7. PubMed ID: 20660047
[TBL] [Abstract][Full Text] [Related]
15. Influence of growth hormone receptor d3 and full-length isoforms on biochemical treatment outcomes in acromegaly.
Bianchi A; Giustina A; Cimino V; Pola R; Angelini F; Pontecorvi A; De Marinis L
J Clin Endocrinol Metab; 2009 Jun; 94(6):2015-22. PubMed ID: 19336510
[TBL] [Abstract][Full Text] [Related]
16. Effects of initial therapy for five years with somatostatin analogs for acromegaly on growth hormone and insulin-like growth factor-I levels, tumor shrinkage, and cardiovascular disease: a prospective study.
Colao A; Auriemma RS; Galdiero M; Lombardi G; Pivonello R
J Clin Endocrinol Metab; 2009 Oct; 94(10):3746-56. PubMed ID: 19622615
[TBL] [Abstract][Full Text] [Related]
17. Outcome of multimodal therapy in operated acromegalic patients, a study in 115 patients.
Albarel F; Castinetti F; Morange I; Conte-Devolx B; Gaudart J; Dufour H; Brue T
Clin Endocrinol (Oxf); 2013 Feb; 78(2):263-70. PubMed ID: 22783815
[TBL] [Abstract][Full Text] [Related]
18. Amelioration of cardiovascular risk factors with partial biochemical control of acromegaly.
Delaroudis SP; Efstathiadou ZA; Koukoulis GN; Kita MD; Farmakiotis D; Dara OG; Goulis DG; Makedou A; Makris P; Slavakis A; Avramides AI
Clin Endocrinol (Oxf); 2008 Aug; 69(2):279-84. PubMed ID: 18194486
[TBL] [Abstract][Full Text] [Related]
19. Predictors of morbidity and mortality in acromegaly: an Italian survey.
Arosio M; Reimondo G; Malchiodi E; Berchialla P; Borraccino A; De Marinis L; Pivonello R; Grottoli S; Losa M; Cannavò S; Minuto F; Montini M; Bondanelli M; De Menis E; Martini C; Angeletti G; Velardo A; Peri A; Faustini-Fustini M; Tita P; Pigliaru F; Borretta G; Scaroni C; Bazzoni N; Bianchi A; Appetecchia M; Cavagnini F; Lombardi G; Ghigo E; Beck-Peccoz P; Colao A; Terzolo M;
Eur J Endocrinol; 2012 Aug; 167(2):189-98. PubMed ID: 22596288
[TBL] [Abstract][Full Text] [Related]
20. Medical treatment of acromegaly: comorbidities and their reversibility by somatostatin analogs.
Tolis G; Angelopoulos NG; Katounda E; Rombopoulos G; Kaltzidou V; Kaltsas D; Protonotariou A; Lytras A
Neuroendocrinology; 2006; 83(3-4):249-57. PubMed ID: 17047390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
